|
|
|
Insider
Information: |
Gasmi Mehdi |
Relationship: |
Director |
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
274,442 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,157,114 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
274,442 |
|
|
Total
Value |
$2,157,114 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-34.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Adverum Biotechnologies, Inc |
ADVM |
Director |
2020-07-20 |
274,442 |
2015-04-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
7,000 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Chief Scientific Officer |
|
2015-08-21 |
4 |
A |
$0.00 |
$0 |
D/D |
29,160 |
36,160 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Chief Scientific Officer |
|
2016-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
161,803 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Chief Science & Tech Officer |
|
2017-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
289,535 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2018-06-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
88,496 |
345,258 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Chief Science & Tech Officer |
|
2018-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,496 |
387,031 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2020-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,496 |
321,418 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2020-06-17 |
4 |
OE |
$4.80 |
$1,286 |
D/D |
268 |
274,710 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-05-07 |
4 |
OE |
$2.75 |
$1,375 |
D/D |
500 |
7,500 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-05-14 |
4 |
OE |
$2.75 |
$1,375 |
D/D |
500 |
7,500 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-05-21 |
4 |
OE |
$2.75 |
$1,375 |
D/D |
500 |
7,500 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-05-28 |
4 |
OE |
$2.75 |
$1,375 |
D/D |
500 |
7,500 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-06-08 |
4 |
OE |
$2.75 |
$1,375 |
D/D |
500 |
7,500 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
SVP,Pharmaceutical Development |
|
2015-06-15 |
4 |
OE |
$2.75 |
$1,375 |
D/D |
500 |
7,500 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2017-04-21 |
4 |
D |
$2.70 |
$1,774 |
D/D |
(657) |
276,085 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-04-14 |
4 |
OE |
$2.75 |
$2,750 |
D/D |
1,000 |
1,000 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-04-21 |
4 |
OE |
$2.75 |
$2,750 |
D/D |
1,000 |
1,000 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-04-28 |
4 |
OE |
$2.75 |
$2,750 |
D/D |
1,000 |
8,000 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2019-04-21 |
4 |
D |
$5.98 |
$3,522 |
D/D |
(589) |
321,418 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2018-04-21 |
4 |
D |
$6.30 |
$3,812 |
D/D |
(605) |
247,762 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2020-06-17 |
4 |
AS |
$25.01 |
$6,703 |
D/D |
(268) |
274,442 |
0 |
% |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2020-05-20 |
4 |
OE |
$4.80 |
$6,725 |
D/D |
1,401 |
275,843 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2017-08-21 |
4 |
D |
$2.50 |
$13,698 |
D/D |
(5,479) |
270,606 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
VP, Pharmaceutical Development |
|
2015-05-07 |
4 |
AS |
$33.28 |
$16,638 |
D/D |
(500) |
7,000 |
0 |
- |
|
ADVM |
Adverum Biotechnologies, ... |
Director |
|
2020-05-21 |
4 |
OE |
$4.80 |
$17,275 |
D/D |
3,599 |
278,041 |
0 |
- |
|
66 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|